Inotek Pharmaceuticals (United States)
Impact in
- Physiology top 5%
- Nitric Oxide and Endothelin Effects
- Adenosine and Purinergic Signaling
-
- PARP inhibition in cancer therapy
Papers in
- Physiology 33
-
- Adaptive optics and wavefront sensing 65
- Optical and Acousto-Optic Technologies 43
- Photorefractive and Nonlinear Optics 30
- Top scholars
- Csaba SzabóLászló VirágRichard G. BarakatJon G. MableyLucas LiaudetI. C. ChangJames C. WyantPál Pacher
- Journals
- Applied Optics (74 papers)Shock (21 papers)Optical Engineering (18 papers)Journal of Applied Physics (12 papers)Critical Care Medicine (12 papers)
- Partner nations
- United StatesHungaryGermany
In The Last Decade
Inotek Pharmaceuticals (United States)
588 papers receiving 26.0k citations
Peers
Comparison fields: 5 of 215
- Physiology 2.1k
- Oncology 5.6k
- Geriatrics and Gerontology 494
- Clinical Biochemistry 942
- Immunology 2.9k
Countries citing scholars working at Inotek Pharmaceuticals (United States)
This map shows the geographic impact of research produced by authors working at Inotek Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Inotek Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inotek Pharmaceuticals (United States) more than expected).
Fields of papers published by authors at Inotek Pharmaceuticals (United States)
This network shows the impact of papers affiliated with Inotek Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Inotek Pharmaceuticals (United States) at the time of their publication.
About Inotek Pharmaceuticals (United States)
In recent decades, authors affiliated with Inotek Pharmaceuticals (United States) have published 648 papers, which have received a total of 28.2k indexed citations . Scholars at this organization have produced 33 papers in Physiology, 159 papers in Atomic and Molecular Physics, and Optics, 99 papers in Oncology, 13 papers in Instrumentation and 24 papers in Surfaces, Coatings and Films on the topics of PARP inhibition in cancer therapy (95 papers), Adaptive optics and wavefront sensing (65 papers), Optical measurement and interference techniques (51 papers), Photonic and Optical Devices (45 papers), Optical and Acousto-Optic Technologies (43 papers), Advanced optical system design (41 papers), Advanced Measurement and Metrology Techniques (37 papers) and Photorefractive and Nonlinear Optics (30 papers). Their work is cited by papers focused on Physiology (2.1k citations), Oncology (5.6k citations), Geriatrics and Gerontology (494 citations), Clinical Biochemistry (942 citations) and Immunology (2.9k citations). Authors at Inotek Pharmaceuticals (United States) collaborate with scholars in United States, Hungary and Germany and have published in prestigious journals including Applied Optics, Shock, Optical Engineering, Journal of Applied Physics and Critical Care Medicine. Some of Inotek Pharmaceuticals (United States)'s most productive authors include Csaba Szabó, László Virág, Richard G. Barakat, Jon G. Mabley, Lucas Liaudet, I. C. Chang, James C. Wyant, Pál Pacher, György Haskó and Andrew L. Salzman.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.